Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Prognostic factors and survival outcomes of first CNS relapse in childhood acute lymphoblastic leukemia : results from the ALL-IC REL 2016 study
Authors:ID Hazar, Volkan (Author)
ID Makiya, Monika (Author)
ID Yalçın, Koray (Author)
ID Tadecilla Cadiu, Juan (Author)
ID Manni, Federico (Author)
ID Reyes Barragan, Andrea (Author)
ID Kavčič, Marko (Author)
ID Prelog, Tomaž (Author)
ID Jazbec, Janez (Author), et al.
Files:.pdf PDF - Presentation file, download (2,43 MB)
MD5: B7FB139CC81324B8EB85CF1341B61168
 
URL URL - Source URL, visit https://www.tandfonline.com/doi/full/10.1080/10428194.2025.2598861
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Acute lymphoblastic leukemia (ALL) is among the most curable pediatric cancers, yet relapse involving the central nervous system (CNS) remains a major therapeutic obstacle. In this prospective cohort, 97 children (aged 1.1–18.2 years) experiencing their first CNS relapse were enrolled in the ALL-IC REL study. Relapses were classified as isolated CNS (i-CNS, n = 43) or combined CNS (c-CNS, n = 54), and patients received treatment through standard- or high-risk regimens, encompassing chemotherapy, cranial irradiation, and allogeneic stem cell transplantation. The estimated 2-year event-free survival was 40.0%, and overall survival 49.4%, closely matching outcomes reported internationally. Survival rates were comparable across i-CNS and c-CNS relapses, while induction failure occurred more frequently in c-CNS. Multivariable analysis identified female sex, T-cell phenotype, and very early relapse as independent predictors of poor prognosis. These results underscore the critical necessity for risk-adapted therapy techniques and the incorporation of innovative medicines into forthcoming procedures.
Keywords:childhood, acute lymphoblastic leukemia, central nervous system relapse, prognostic factors, survival, hematopoietic stem cell transplantation
Publication status:Published
Publication version:Version of Record
Year of publishing:2026
Number of pages:str. 416-423
Numbering:Vol. 67, no. 2
PID:20.500.12556/DiRROS-27745 New window
UDC:616-053.2
ISSN on article:1029-2403
DOI:10.1080/10428194.2025.2598861 New window
COBISS.SI-ID:263367683 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 5. 1. 2026;
Publication date in DiRROS:24.02.2026
Views:195
Downloads:59
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Leukemia and lymphoma
Shortened title:Leuk. lymphoma
Publisher:Harwood Academic Publishers.
ISSN:1029-2403
COBISS.SI-ID:521459993 New window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:akutna limfoblastna levkemija, otroci, ponovitev bolezni, centralni živčni sistem, prognostični dejavniki, preživetje, presaditev hematopoetskih matičnih celic


Back